Alfa Laval shares ticked higher after the company announced what it described as its biggest single order to date: a SEK 1.1 billion contract to provide pre-treatment technology for Hydrotreated Vegetable Oil (HVO) at a new biorefinery being developed by Acelen in Brazil. The agreement will be executed in phases, with deliveries scheduled through 2029.
The Swedish engineering firm said the order covers HVO pre-treatment equipment. HVO is a renewable diesel fuel manufactured from vegetable oils and other renewable feedstocks. Alfa Laval’s contract represents a milestone in the company’s order book as its largest-ever single award.
Analysts have factored the order into near-term expectations. Citi analysts noted:
“On our sensitivity, Alfa’s 2Q group orders now likely at SEK 19.3bn, 7% above Street (likely Food/Pharma orders at SEK 7.4bn, 15% above Street).”
Market commentary accompanying the announcement highlighted that the SEK 1.1 billion award is expected to contribute to Alfa Laval’s second-quarter results. The analyst projection of SEK 19.3 billion for total group orders places the company above consensus by roughly 7%.
Key aspects of the announcement are straightforward: the contract value is SEK 1.1 billion; the scope is HVO pre-treatment technology for Acelen’s new biorefinery in Brazil; and deliveries are planned in phases through 2029. The transaction is notable primarily because the company itself characterizes it as the largest single order in its history.
Investors responded to the news with a modest share-price move, reflecting the market’s reception of the size and timing of the order and its potential near-term contribution to reported orders in the second quarter.
Summary
Alfa Laval has secured a SEK 1.1 billion contract to supply HVO pre-treatment technology for Acelen’s new Brazilian biorefinery. The work will be delivered in stages through 2029 and is expected to support the company’s second-quarter order intake, with analysts forecasting group orders of SEK 19.3 billion, about 7% above consensus.
Key points
- Alfa Laval received a SEK 1.1 billion order to supply HVO pre-treatment technology for Acelen’s new biorefinery in Brazil.
- The contract will be carried out in phases through 2029 and is the company’s largest single order to date.
- Analysts project Alfa Laval’s 2Q group orders at SEK 19.3 billion, approximately 7% higher than market expectations, and the order is expected to contribute to those results.
Risks and uncertainties
- Timing and recognition - the order is to be fulfilled in phases through 2029, which introduces timing uncertainty for when revenue and orders will be recognized.
- Expectation gap - analysts have raised their estimates and expect group orders of SEK 19.3 billion; actual reported orders could differ from these projections.
- Concentration of impact - because the award is the company’s largest single order to date, its materiality to short-term order metrics and investor perception could be significant.